|
|
|
|
|
|
|
|
Craig Liddell is an experienced executive and respected senior-level scientist with high-caliber management qualifications, proven leadership talents, distinguished academic career, and extensive experience managing dynamic technology, biotechnology and biopharmaceutical businesses. Expert in the planning, design and development of scientifically and commercially significant products, processes, services and technologies. Successful in meeting business, financial and operational performance goals in biomedical R&D and IT domains. Seasoned presenter, negotiator and fund-raiser. Uncompromising ethics and integrity. Served as corporate officer, chief science officer and key member of executive leadership teams of private and publicly traded biotechnology enterprises. Held frontline roles in two major restructuring events at Paradigm Genetics Inc, presenting and securing public and private financings to fund several early stage and mid-stage life sciences companies.
At Paradigm Genetics Inc. he established, built and managed teams of over 80 staff in informatics and bioinformatics to deliver on over $160 million in commercial contracts. Wrote and won $22.8 million grant from NIST-ATP — largest-ever bioinformatics grant awarded by NIST or any other competitive grant body in the U.S. Contributed to successful IPO of Paradigm Genetics Inc during down-turned market in 2000. Dr Liddell successfully launched Paradigm Genetics Inc healthcare business in 2000 and secured ~$50 million in multi-year commitments by 2001. The company recently sold the healthcare business to Clinical Data Inc for ~$12M. The company sold the agricultural business to MONSANTO Corp in 2004. Dr Liddell helped found and establish Artesian Therapeutics Inc, a start-up cardiovascular therapeutics company, with a capital raise of just under $6M in 2002. The company was recently sold to CARDIOME Pharma Inc for $64M.
Dr Liddell founded Epacris Inc in late 2005 and assembled a talented management team to launch the company. He assisted several small companies in 2004 and 2005 with fund raising, sales and marketing and executive management and leadership including BioFortis Inc of Baltimore MD – a Biomedical research information technology company. He is currently Chief Executive of AMULET Pharmaceuticals Inc of Baltimore MD, a medical device company. Dr Liddell remains a Director of BioFortis Inc.
|
|
Advanced Technology in Support of Analytics in the Life Sciences
Craig Liddell, Epacris
Epacris Inc delivers next generation web based search providing relevance, context and interactivity demanded by the professional search market segment. The healthcare industry today is the last frontier in the information revolution. Information drives decisions at every level and every stage of the healthcare industry from drug discovery and development to delivery and reimbursement. Yet information could not be more inaccessible if it had been planned from the beginning, information is held by proprietary interests and buried by the sheer volume of information. Adverse drug reactions, current best practices and cutting edge research information is far too difficult for medical and science professionals to access in a timely and usable fashion leading to huge inefficiencies and wasted opportunities in an already expensive and inefficient healthcare system.
The Epacris Inc search engine is built from multiple runs of proprietary indexing tools over the same content to build up a relevance map of the facts in the content. Epacris Inc allows a unified search of large collections of canonical documents; the result is a user experience like nothing available on the web today. The company's proprietary technology improves the relevance of search results to any query of the index by leveraging the benefits of associating multiple technologies to dramatically improve the probability of accurate and relevant search results.
All authoritative facts have a history, context and assumptions built into them, so simple database or term based search rarely satisfies the needs of busy professionals without additional information.
Epacris Inc fact-based search is fundamentally a new generation of search because it is based on advanced text mining, natural language processing and advanced text analytics; technologies that are focused on analysis pattern recognition and discovery of knowledge not management, retrieval and keyword search. Text mining, NLP and analytics are used in enterprise information retrieval (IR) applications with great success and Epacris Inc brings the power of these technologies to the web for the first time.
Epacris Inc is launching a web based search engine for the biomedical peer reviewed literature in 2007 and plans releases of vertical search engines in additional fields from 2008.
|
|
|
|
|
|
|
|
|
|
|
